We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SER market cap is 304.75M. The company's latest EPS is USD -0.3901 and P/E is -20.58.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8k | 10k | 9k | 67k | 56k |
| Operating Income | -1.78M | -2.16M | -1.89M | -2.36M | -3.56M |
| Net Income | -2.7M | -3.28M | -2.67M | -5.4M | -3.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.73M | 1.87M | 144k | 34k | 142k |
| Operating Income | -12.56M | -10.67M | -8.04M | -6.98M | -9.96M |
| Net Income | -12.15M | -10.87M | -8.68M | -10.46M | -14.8M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.24M | 12.53M | 12.28M | 12.21M | 11.97M |
| Total Liabilities | 20.56M | 32.54M | 34.57M | 3.9M | 6.61M |
| Total Equity | -17.32M | -20.01M | -22.3M | -27.65M | 5.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.44M | 3.93M | 3.15M | 3.24M | 11.97M |
| Total Liabilities | 4.83M | 9.32M | 15.03M | 20.56M | 6.61M |
| Total Equity | 2.62M | -5.4M | -11.88M | -17.32M | 5.36M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.94M | -1.87M | -3.88M | -5.75M | -7.8M |
| Investing | N/A | -10M | -10M | -10M | -10M |
| Financing | 6M | 11.5M | 13.5M | 15.5M | 17.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.16M | -7.82M | -7.86M | -5.94M | -7.8M |
| Investing | -361k | -20k | 666k | N/A | -10M |
| Financing | 6.27M | 5.96M | 7.25M | 6M | 17.5M |
| Market Cap | 304.75M |
| Price to Earnings Ratio | -20.58 |
| Price to Sales Ratio | 2.17k |
| Price to Cash Ratio | 882.42 |
| Price to Book Ratio | 56.88 |
| Dividend Yield | - |
| Shares Outstanding | 37.95M |
| Average Volume (1 week) | 19.83k |
| Average Volume (1 Month) | 6.62k |
| 52 Week Change | -31.25% |
| 52 Week High | 19.93 |
| 52 Week Low | 7.86 |
| Spread (Intraday) | 9.53 (74.69%) |
| Company Name | Serina Therapeutics Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://serinatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
